share_log

Barclays Maintains Overweight on Amdocs, Raises Price Target to $115

Benzinga ·  Feb 9 03:14

Barclays analyst Tavy Rosner maintains Amdocs (NASDAQ:DOX) with a Overweight and raises the price target from $105 to $115.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment